Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.

Abstract : B cells are involved in immune thrombocytopenia (ITP) pathophysiology by producing antiplatelet auto-antibodies. However more than a half of ITP patients do not respond to B cell depletion induced by rituximab (RTX). The persistence of splenic T follicular helper cells (TFH) that we demonstrated to be expanded during ITP and to support B cell differentiation and antiplatelet antibody-production may participate to RTX inefficiency. Whereas it is well established that the survival of TFH depends on B cells in animal models, nothing is known in humans yet. To determine the effect of B cell depletion on human TFH, we quantified B cells and TFH in the spleen and in the blood from ITP patients treated or not with RTX. We showed that B cell depletion led to a dramatic decrease in splenic TFH and in CXCL13 and IL-21, two cytokines predominantly produced by TFH. The absolute count of circulating TFH and serum CXCL13 also decreased after RTX treatment, whatever the therapeutic response. Therefore, we showed that the maintenance of TFH required B cells and that TFH are not involved in the inefficiency of RTX in ITP.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Lnc - Université de Bourgogne Connectez-vous pour contacter le contributeur
Soumis le : mercredi 5 juillet 2017 - 11:15:09
Dernière modification le : vendredi 14 janvier 2022 - 03:08:23



Sylvain Audia, Marzia Rossato, Malika Trad, Maxime Samson, Kim Santegoets, et al.. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.. Journal of Autoimmunity, Elsevier, 2017, 77, pp.89-95. ⟨10.1016/j.jaut.2016.11.002⟩. ⟨hal-01556486⟩



Les métriques sont temporairement indisponibles